Search results for "stance"

showing 10 items of 7708 documents

Role of biomarkers in the management of antibiotic therapy : an expert panel review : I - currently available biomarkers for clinical use in acute in…

2013

Abstract In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose of this expert panel review was to examine currently available literature on the potential role of biomarkers to improve antimicrobial prescribing, by answering three questions: 1) Which are the biomarkers available for this purpose?; 2) What is their potential role in the initiation of antibiotic therapy?; and 3) What is their role in the decision to stop antibiotic therapy? To ans…

medicine.medical_specialtymedicine.drug_class[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]AntibioticsMEDLINEContext (language use)ReviewCritical Care and Intensive Care MedicineProcalcitoninC-reactive proteinsuPARsepsis03 medical and health sciences0302 clinical medicineAntibiotic resistanceemergency medicineAntibiotic therapy[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Medicine030212 general & internal medicineIntensive care medicine030304 developmental biologyddc:6160303 health sciencessepticemie[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]business.industryPresepsin[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieproADMsTREM-1infection3. Good healthSanté publique et épidémiologie[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBiomarker (medicine)infection;sepsis;emergency medicine;biomarker;procalcitonin;C-reactive protein;sTREM-1;suPAR;proADM;resepsinbiomarker[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieresepsinbusinessbiomarqueurBiomarkersprocalcitonin
researchProduct

FLT3 as a therapeutic target in AML: still challenging after all these years

2010

Abstract Mutations within the FMS-like tyrosine kinase 3 (FLT3) gene on chromosome 13q12 have been detected in up to 35% of acute myeloid leukemia (AML) patients and represent one of the most frequently identified genetic alterations in AML. Over the last years, FLT3 has emerged as a promising molecular target in therapy of AML. Here, we review results of clinical trials and of correlative laboratory studies using small molecule FLT3 tyrosine kinase inhibitors (TKIs) in AML patients. We also review mechanisms of primary and secondary drug resistance to FLT3-TKI, and from the data currently available we summarize lessons learned from FLT3-TKI monotherapy. Finally, for using FLT3 as a molecul…

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentImmunologyBiologyBiochemistryTyrosine-kinase inhibitorTargeted therapychemistry.chemical_compoundfluids and secretionshemic and lymphatic diseasesInternal medicinemedicineHumansProtein Kinase InhibitorsQuizartinibHematologyMyeloid leukemiaCancerhemic and immune systemsCell BiologyHematologymedicine.diseaseLeukemia Myeloid Acutefms-Like Tyrosine Kinase 3chemistryDrug Resistance Neoplasmembryonic structuresCancer researchTyrosine kinaseCrenolanibBlood
researchProduct

Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

1989

Recombinant DNA technology has been central in answering some of the most relevant questions in the research of regulation of the functional status of hematopoietic progenitor cells and their progeny. This leading article will focus on recent results that have emerged from studies utilizing recombinant molecules that control hematopoietic blood cell development and activation. The following features will be detailed: The molecular and biological characteristics and biochemistry of hematopoietic growth factors, synergizing factors and releasing factors, their role in the regulation of hematopoiesis and activation of normal and leukemic cells, their cellular sources, and regulation of product…

medicine.medical_specialtymedicine.medical_treatmentBiologylaw.inventionBlood celllawInternal medicinemedicineAnimalsHumansProgenitor cellGrowth SubstancesCells CulturedHematologyCell growthGrowth factorHematologyGeneral MedicineHematopoietic Stem CellsIn vitroCell biologyHematopoiesisHaematopoiesismedicine.anatomical_structureImmunologyRecombinant DNAPeptidesBlut
researchProduct

Source strength determination in iridium-192 and cobalt-60 brachytherapy : A European survey on the level of agreement between clinical measurements …

2021

Background and purpose: Brachytherapy treatment outcomes depend on the accuracy of the delivered dose distribution, which is proportional to the reference air-kerma rate (RAKR). Current societal recommendations require the medical physicist to compare the measured RAKR values to the manufacturer source calibration certificate. The purpose of this work was to report agreement observed in current clinical practice in the European Union. Materials and methods: A European survey was performed for high- and pulsed-dose-rate (HDR and PDR) highenergy sources (Ir-192 and Co-60), to quantify observed RAKR differences. Medical physicists at eighteen hospitals from eight European countries were contac…

medicine.medical_specialtymedicine.medical_treatmentBrachytherapyTreatment outcomeBrachytherapyR895-920HDRDose distributionMedical physicistMedical physics. Medical radiology. Nuclear medicinePDRmedicinemedia_common.cataloged_instanceRadiology Nuclear Medicine and imagingMedical physicsOriginal Research ArticleEuropean unionRC254-282media_commonRadiationCobalt 60 brachytherapybusiness.industryRAKRNeoplasms. Tumors. Oncology. Including cancer and carcinogensCertificateSource strengthCalibrationRadiologi och bildbehandlingbusinessRAKR; Calibration; HDR; PDR; BrachytherapyRadiology Nuclear Medicine and Medical Imaging
researchProduct

Hyperinsulinemia, hyperproinsulinemia and insulin resistance in the metabolic syndrome.

1996

For better comprehension of the metabolic syndrome, it is necessary to differentiate the effect of insulin on glucose metabolism on the one hand, and on other metabolic activities on the other hand. Whereas glucose utilization is affected by insulin resistance, the effect of insulin on lipid metabolism, ion and aminoacid transport does not seem to be diminished. Lipid metabolism, however, seems to play a crucial role in the induction of the vicious cycle. Increased energy and fat ingestion may be due to an increased number of galanin secreting cells in the hypothalamus. The excessive fat intake results in an increased rate of release of insulin and increased influx of triglycerides into the…

medicine.medical_specialtymedicine.medical_treatmentCarbohydrate metabolismFatty Acids NonesterifiedHyperproinsulinemiaModels BiologicalCellular and Molecular NeuroscienceInsulin resistanceInternal medicineHyperinsulinismmedicineHyperinsulinemiaAnimalsHomeostasisHumansInsulinMolecular BiologyTriglyceridesPharmacologyChemistryInsulinCell BiologySyndromemedicine.diseaseEndocrinologyAminoacid transportMolecular MedicineMetabolic syndromeInsulin ResistanceHyperinsulinismProinsulinExperientia
researchProduct

Metabolic response to 6-week aerobic exercise training and dieting in previously sedentary overweight and obese pre-menopausal women: A randomized tr…

2014

AbstractBackground: The aim of this study was to compare 6 weeks short-term moderate intensity aerobic exercise and dieting on serum metabolomicsand cardio-metabolic risk factors in pre-menopausal women.Methods: Ninety previously inactive overweight and obese (BMI 25e35 kg/m 2 ) women (age 41.5 7.6 years) were randomized to either a6-week Nordic walking exercise program (EX, n ¼ 45) or dietary counseling group (DI, n ¼ 45). Body composition, serum glucose, insulin andlipids were measured. Serum low-molecular-weight metabolites and lipid constituents were analyzed by nuclear magnetic resonance spec-troscopy. Measurements were done at baseline and 7 days after the last training session.Result…

medicine.medical_specialtymedicine.medical_treatmentDietingPhysical Therapy Sports Therapy and RehabilitationOverweightlaw.inventionlcsh:GV557-1198.995Insulin resistanceRandomized controlled trialWeight losslawInternal medicinemedicineMetabolomicsAerobic exerciseWomenOrthopedics and Sports Medicinelcsh:Sports medicineExerciselcsh:Sportsbusiness.industryInsulinta3141Metabolismmedicine.diseaseMetabolismEndocrinologymedicine.symptomlcsh:RC1200-1245businessDietingJournal of Sport and Health Science
researchProduct

Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X

2003

Magnesium (Mg) is one of the most abundant ions present in living cells and its plasma concentration is remarkably constant in healthy subjects. Plasma and intracellular Mg concentrations are tightly regulated by several factors. Among them, insulin seems to be one of the most important. In vitro and in vivo studies have demonstrated that insulin may modulate the shift of Mg from extracellular to intracellular space. Intracellular Mg concentration has also been shown to be effective in modulating insulin action (mainly oxidative glucose metabolism), offset calcium-related excitation-contraction coupling, and decrease smooth cell responsiveness to depolarizing stimuli. A poor intracellular M…

medicine.medical_specialtymedicine.medical_treatmentGlucose uptakeClinical BiochemistryBiologyCarbohydrate metabolismBiochemistryInsulin resistanceDiabetes mellitusInternal medicinemedicineHumansInsulinMagnesiumMolecular BiologyMetabolic SyndromeInsulinGeneral Medicinemedicine.diseaseOxidative StressInsulin receptorEndocrinologyDiabetes Mellitus Type 2Hypertensionbiology.proteinMolecular MedicineInsulin ResistanceVanadatesMetabolic syndromeIntracellularMolecular Aspects of Medicine
researchProduct

The Effects of Epinine on Arterial Blood Pressure and Regional Vascular Resistances in Anesthetized Rats

1998

1. We carried out experiments in anesthetized rats to study the hemodynamic effects of intravenous injections of epinine. 2. Epinine (1-320 micrograms/kg) produced a biphasic effect on mean arterial blood pressure (n = 30). At doses lower than 40 micrograms/kg, arterial blood pressure decreased (by as much as 21.5 +/- 3.4%), though at higher doses it increased dose dependently (by as much as 73.2 +/- 14.5%). Epinine also produced bradicardia in a dose-dependent manner (by as much as 26.4 +/- 4.9%). Sulpiride (100 micrograms/kg) suppressed the hypotensive effect of epinine but did not change the hypertensive effect. In the presence of prazosin (1,000 micrograms/kg), arterial blood pressure r…

medicine.medical_specialtymedicine.medical_treatmentHemodynamicsBlood PressureAntiarrhythmic agentUrethaneRenal CirculationHeart RateInternal medicinemedicinePrazosinAnimalsSplanchnic CirculationRats WistarPharmacologybusiness.industryBlood flowRatsDeoxyepinephrinemedicine.anatomical_structureBlood pressureEndocrinologyDopamine AgonistsCirculatory systemVascular resistanceVascular ResistanceSulpiridebusinessAnesthetics Intravenousmedicine.drugGeneral Pharmacology: The Vascular System
researchProduct

Effects of dietary conjugated linoleic acids in the control of adiposity and obesity‐related disorders

2007

The body fat-lowering effect of conjugated linoleic acids (CLA) in experimental animals has attracted much interest because of the potential use of CLA as weight loss agents in humans. The objective of this review was to give an overview of the results from human intervention trials. The review also addresses experimental studies in animal models and in cultured cells. CLA appear to provoke fat mass loss and an increase of fat-free mass in rodents, but the results in humans are inconsistent and much less clear than in rodents. Thus, the results of studies in humans do not support a body fat-lowering effect of CLA. There are indications from animal studies that the trans-10, cis-12 CLA isome…

medicine.medical_specialtymedicine.medical_treatmentLinoleic acidConjugated linoleic acidBiologyIndustrial and Manufacturing Engineeringchemistry.chemical_compoundInsulin resistanceLiver steatosisInternal medicinemedicinechemistry.chemical_classificationintegumentary systemInsulinfood and beveragesGeneral Chemistrymedicine.diseaseObesityEndocrinologyBiochemistrychemistrylipids (amino acids peptides and proteins)Animal studiesFood ScienceBiotechnologyPolyunsaturated fatty acidEuropean Journal of Lipid Science and Technology
researchProduct

Dilation of the ductus venosus by stent implantation increases placental blood perfusion in fetal sheep.

2006

The reduction of resistance to flow in the ductus venous (DV) and a decrease of blood supply to the liver serve for the survival of the fetus during hypoxia. The present study investigated the influence of the increased diameter of the DV on placental blood perfusion.In 15 ewes with twin pregnancies at gestational ages of 117 +/- 4 days, a stent (4 or 5 mm) was placed into the DV of 1 twin (DV(stent) group) under ultrasound guidance. Blood flow rates in the umbilical vein (UV) and DV of both fetuses were measured using Doppler ultrasound. Eight pairs of twin fetuses were included for the final analysis.The dilatation of the DV increased the blood flow volume rate passed through the DV from …

medicine.medical_specialtymedicine.medical_treatmentPulsatile flowGestational AgeHepatic VeinsFetal HypoxiaSensitivity and SpecificityUmbilical veinRandom AllocationPregnancyInternal medicinemedicineAnimalsPlacental CirculationProbabilityFetusSheepbusiness.industryFetoscopyObstetrics and GynecologyStentBlood flowSurgeryDisease Models Animalmedicine.anatomical_structureLiverUltrasonography Doppler PulsedPulsatile FlowCardiologyVascular resistancePregnancy AnimalFemaleStentsVascular ResistancebusinessPerfusionDuctus venosusAmerican journal of obstetrics and gynecology
researchProduct